Drug delivery and formulation - Page 1

Nexavar given green light to treat thyroid cancer
Friday, May 30, 2014 by Nexavar, the drug developed by Bayer and Amgen unit Onyx Pharmaceuticals to treat advanced kidney and liver cancers, has been approved for the treatment of the most common form of...

GSK diabetes drug Eperzan approved in Europe
Thursday, March 27, 2014 by The European Commission has granted marketing authorisation for GlaxoSmithKline's (GSK) once-weekly diabetes treatment, Eperzan (albiglutide).

Pfizer announces positive top-line results of landmark CAPiTA evaluating efficacy of Prevenar 13
Monday, February 24, 2014 by Pfizer Inc has announced that the 'Community-Acquired Pneumonia Immunisation Trial in Adults' (CAPiTA) − the landmark study of approximately 85,000 subjects evaluating the efficacy...

Novartis drug Lucentis approved by Japanese regulatory bodies
Friday, February 21, 2014 by Lucentis® (ranibizumab) has been approved by Japanese regulatory bodies for a fourth indication: the treatment of patients with diabetic macular edema (DME), a leading cause of...

GSK announces start of Phase lll study for mepolizumab in patients with EGPA
Tuesday, February 18, 2014 by GlaxoSmithKline (GSK) has announced the start of a Phase III study to evaluate the efficacy and safety of mepolizumab, an investigational IL-5 antagonist, in patients with...